Collplant Biotechnologies Ltd's Comment on Supply Chain
The company faces risks related to raw materials and supplies, quality control, personnel shortages, regulatory compliance, capacity limitations, and external events such as natural disasters or war. Regulatory authorities may audit manufacturing facilities, including third-party contractors, and non-compliance can result in costly remedial measures or suspension of operations. Disruptions in internal manufacturing could delay clinical trials and commercial supply, requiring expensive third-party manufacturing arrangements. In early 2024, a mechanical failure at the Yessod Hama’ala facility caused a temporary shutdown, and the facility was subsequently closed for an extended period due to war-related risks near the Lebanon border. The company lacks experience in producing commercial quantities, which may lead to quality issues and product recalls, potentially affecting its business and financial prospects.
Collplant Biotechnologies Ltd's Comment on Supply Chain
The company faces risks related to raw materials and supplies, quality control, personnel shortages, regulatory compliance, capacity limitations, and external events such as natural disasters or war. Regulatory authorities may audit manufacturing facilities, including third-party contractors, and non-compliance can result in costly remedial measures or suspension of operations. Disruptions in internal manufacturing could delay clinical trials and commercial supply, requiring expensive third-party manufacturing arrangements. In early 2024, a mechanical failure at the Yessod Hama’ala facility caused a temporary shutdown, and the facility was subsequently closed for an extended period due to war-related risks near the Lebanon border. The company lacks experience in producing commercial quantities, which may lead to quality issues and product recalls, potentially affecting its business and financial prospects.
Sources:
Collplant Biotechnologies Ltd's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Collplant Biotechnologies Ltd’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
